VICTORIA, June 19, 2015 /CNW/ - T-Bird Pharma Inc.
(TSXV:TPI) ("T-Bird" or the "Company"), a
licensed producer to cultivate and sell marijuana under the
Marihuana for Medical Purposes Regulations (Canada), is pleased to announce that the
Company has changed its name to "Emerald Health Therapeutics Inc.",
as approved by the board of directors of the Company and the TSX
Venture Exchange. Effective June 23,
2015, the Company's shares will begin trading on the TSX
Venture Exchange under the new symbol "EMH".
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. wholly owns Emerald Health
Botanicals Inc. (formerly Thunderbird Biomedical Inc.) Emerald
Health Botanicals Inc. was the fifth company in Canada to receive a License under the
Marihuana for Medical Purposes Regulations (Canada) to cultivate and sell medical cannabis
out of its facility located in Victoria,
British Columbia. For more information please
visit: www.emerald.care.
ON BEHALF OF THE BOARD
"Avtar Dhillon"
Chairman
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute
forward-looking statements, within the meaning of applicable
securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking statements" involve
known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in
such statements.
Forward-looking statements include, but are not limited to,
statements with respect to commercial operations, including
production and sales of medical marijuana, anticipated revenues,
projected size of market, quantities of future medical marijuana
production, completion of production facilities and other
information that is based on forecasts of future results, estimates
of amounts not yet determinable and assumptions of management.
Emerald Health Therapeutics, Inc. (the "Company") does not
intend, and does not assume any obligation, to update these
forward-looking statements except as required by law. These
forward-looking statements involve risks and uncertainties relating
to, among other things, results of production and sale activities,
the Company's historical experience with medical marijuana
operations, uninsured risks, regulatory changes, availability of
production facilities, timeliness of government approvals and the
granting of permits and licenses, changes in prices, actual
operating and financial performance of facilities, equipment and
processes relative to specifications and expectations. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE Emerald Health Therapeutics Inc.